Most nAbs against the SARS-CoV-2 target the spike protein’s N-terminal (NTD) and receptor-binding (RBD) domains. Nonetheless, ...
Researchers investigated the neutralizing antibody titers against the newly emergent BQ.1, BQ.1.1, XBB, and XBB.1 SARS-CoV-2 ...
Zimbabwe's approval of the long-acting cabotegravir (CAB-LA) for use by HIV-negative people to reduce the risk of getting HIV ...
Over time, SARS-CoV-2 has shown a unique evolutionary feature termed saltation – the ability to produce variants ...
Researchers investigated the effects of early postnatal antibiotic exposure among infants in the participating networks of ...
In this interview, Dr. Marina Danalache, Lab leader at the Laboratory of Cell Biology, Department of Orthopedic Surgery, ...
To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, ...
They've learned that dating apps are the most efficient way to inform users that people they previously met on the sites may ...
During a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned ...
Researchers assessed the taxonomic characteristics of the intestinal (gut) microbiome in patients with active severe acute ...
In this article, e-con describes how cameras combined with AI systems have revolutionized remote patient monitoring.
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in ...